PMA device
Ladar Vision Excimer Laser System (Hyperopia)
Alcon Laboratories · Excimer Laser System (LZS, Class III) · First FDA decision Jan 7, 2000, newest Sep 22, 2000Nearsightedness and refractive error
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
PMA pathway
Device trials
1
Naming "Ladar Vision"
MAUDE reports
0
Brand "Ladar Vision", since 2015
PubMed studies
2
Mentioning "Ladar Vision"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Ladar Vision Excimer Laser System (Hyperopia)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- LADAR VISION EXCIMER LASER SYSTEM (HYPEROPIA)PMA supplement
P970043-S007 · Decided Sep 22, 2000 · 385 days after receipt · Panel Track
Device type: Excimer laser system (LZS) · Ophthalmology
- LADAR VISION EXCIMER LASER SYSTEMPMA supplement
P970043-S006 · Decided Jan 7, 2000 · 107 days after receipt · Normal 180 Day Track
Device type: Excimer laser system (LZS) · Ophthalmology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Ladar Vision", any status and sponsor, newest update first.
University of Texas Southwestern Medical CenterAcademic, hospital or other
NCT00344838 · 458 participants · Start Sep 2003 · Primary completion Dec 2015
Device: Comparison of LADAR CustomLasik and VISX Wavefront System custom laser ablation devices · For: Customized Laser Ablation
Sites: Dallas, Texas
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Ladar Vision", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code LZS
7,603 reports: 949 malfunction, 6,624 injury, 12 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- LADAR6000 Excimer Laser SystemTerminated
Alcon Refractive Horizons, Inc.
Z-0854-2007 · Started Feb 21, 2007 · Posted by FDA Jun 5, 2007
Reason given: Observed 'central islands' in patients following custom myopia laser procedures using the LADAR6000 Excimer Laser. (On May 11, 2007, Alcon notified consignees that the device software programs for CustomCornea Myopia and CustomCornea Myopia with Astigmatism of the device would be deactivated)
Cause as FDA categorized it: Other · Device type: Excimer Laser System (LZS)
- LADARVision Excimer Laser System.Terminated
Z-1147-06 · Started Aug 1, 2005 · Posted by FDA Jun 21, 2006
Reason given: Alcon has identified a software error associated with the use of the Measuring Mode (ruler tool) on the LADARVision4000 Excimer Laser Systems. Use of this feature after alignment of the horizontal reference line will negate compensation for cyclotorsion on CustomCornea procedures, possibly adversely affecting clinical...
Cause as FDA categorized it: Other · Device type: Excimer Laser System (LZS)
Published research
The most relevant PubMed records for "Ladar Vision"[tiab]. The summary above synthesizes these.
- Flap-induced and laser-induced ocular aberrations in a two-step LASIK procedure.
Waheed S, Chalita MR, Xu M, et al. · J Refract Surg · 2005Comparative Study, Research Support, Non-U.S. Gov't
- Wavefront-guided treatment of symptomatic eyes using the LADAR6000 excimer laser.
Carones F, Vigo L, Scandola E · J Refract Surg · 2006
Other devices of this type
Also filed under product code LZS.
- WaveLight EX500 LaserAlcon Laboratories, Inc. · PMA 2025
- Wavelight Allegretto Wave Excimer Laser SystemAlcon Laboratories, Inc. · PMA 2013
- STAR S4 IR Excimer Laser System and iDESIGN Refractive StudioAmo Manufacturing USA, LLC · PMA 2019
- Nidek EC-5000 Excimer Laser SystemNidek Co., Ltd. · PMA 2018
- Bausch & Lomb Technolas T217Z Zyoptix Laser SystemTechnolas Perfect Vision GmbH · PMA 2010
- Ladarvision 4000 Excimer Laser System and the Ladar 6000 Excimer Laser SystemAlcon Laboratories · PMA 2006
- Allegretto Wave Eye-Q Excimer Laser SystemAlcon Laboratories, Inc. · PMA 2015
- Technolas 217A Excimer Laser SystemTechnolas Perfect Vision GmbH · PMA 2003
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.